| |
Collected and analyzed with TLC (%)
|
Samples included in disintegration test (% of TLC tested)
|
Expired before analysis
|
TLC failures
|
Disinteg-ration test failures
|
Average costs (USD)
|
|---|
|
ACT
|
|
Artemether-lumefantrine
|
177 (41%)
|
102 (58%)
|
3
|
1
|
0
|
7.6
|
|
Artesunate-amodiaquine
|
42 (10%)
|
22 (52%)
|
6
|
0
|
0
|
7.2
|
|
Artesunate-SP
|
36 (8%)
|
26 (72%)
|
1
|
0
|
0
|
8.5
|
|
Dihydroartemisinin-piperaquine
|
38 (9%)
|
33 (86%)
|
1
|
0
|
0
|
9.9
|
|
Artesunate-mefloquine
|
22 (5%)
|
5 (23%)
|
1
|
0
|
0
|
9.7
|
|
Dihydroartemisinin-piperaquine- trimethoprim
|
13 (3%)
|
12 (92%)
|
0
|
0
|
0
|
9.3
|
|
Dihydroartemisinin-SP
|
7 (2%)
|
0 (0%)
|
0
|
0
|
0
|
4.5
|
|
Artemisinin-piperaquine
|
2 (<1%)
|
0 (0%)
|
0
|
0
|
0
|
10.1
|
|
Artemisinin-naphtoquine
|
1 (<1%)
|
0 (0%)
|
0
|
0
|
0
|
NR
|
|
Other
|
|
Quinine
|
43 (10%)
|
34 (79%)
|
0
|
1
|
0
|
9.6
|
|
Sulphadoxine-pyrimethamine
|
40 (9%)
|
26 (65%)
|
0
|
0
|
1
|
2.2
|
|
Mefloquine
|
4 (<1%)
|
2 (50%)
|
0
|
0
|
0
|
33.3
|
|
Atovaquone-proguanil
|
2 (<1%)
|
0 (0%)
|
0
|
0
|
0
|
24.2
|
|
Proguanil
|
2 (<1%)
|
0 (0%)
|
0
|
0
|
0
|
16.5
|
|
Proguanil-chloroquine
|
2 (<1%)
|
0 (0%)
|
1
|
0
|
0
|
25.2
|
|
Pyrimethamine
|
1 (<1%)
|
0 (0%)
|
0
|
0
|
0
|
NR
|
|
Total
|
432 (100%)
|
266 (62%)
|
13 (3%)
|
2
|
1
|
8.1
|
-
TLC semi-quantitative thin-layer chromatography.
